{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:44:57Z","timestamp":1760132697565,"version":"3.37.3"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T00:00:00Z","timestamp":1715385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T00:00:00Z","timestamp":1715385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32"],"award-info":[{"award-number":["N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s10549-024-07327-5","type":"journal-article","created":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T02:01:17Z","timestamp":1715392877000},"page":"65-79","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Ductal carcinoma in situ and cause-specific mortality among younger and older postmenopausal women: the Women\u2019s Health Initiative"],"prefix":"10.1007","volume":"207","author":[{"given":"Kathy","family":"Pan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca A.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4212-6184","authenticated-orcid":false,"given":"Rowan T.","family":"Chlebowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Piela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maeve","family":"Mullooly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael S.","family":"Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas E.","family":"Rohan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Wactawski-Wende","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JoAnn E.","family":"Manson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne E.","family":"Mortimer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorothy","family":"Lane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Kruper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,11]]},"reference":[{"key":"7327_CR1","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1093\/jnci\/djn344","volume":"100","author":"LA Brinton","year":"2008","unstructured":"Brinton LA, Sherman ME, Carreon JD et al (2008) Recent trends in breast cancer among younger women in the United States. J Natl Cancer Inst 100:1643\u20131648","journal-title":"J Natl Cancer Inst"},{"key":"7327_CR2","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s10549-014-3168-3","volume":"148","author":"A Berkman","year":"2014","unstructured":"Berkman A, B FC, Ades PA et al (2014) Racial differences in breast cancer, cardiovascular disease, and all-cause mortality among women with ductal carcinoma in situ of the breast. Breast Cancer Res Treat 148:407\u2013413","journal-title":"Breast Cancer Res Treat"},{"key":"7327_CR3","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1002\/ijc.30413","volume":"140","author":"W He","year":"2017","unstructured":"He W, Sofie Lindstrom L, Hall P et al (2017) Cause-specific mortality in women with breast cancer in situ. Int J Cancer 140:2414\u20132421","journal-title":"Int J Cancer"},{"key":"7327_CR4","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1200\/JCO.2010.33.0472","volume":"29","author":"MA Schonberg","year":"2011","unstructured":"Schonberg MA, Marcantonio ER, Ngo L et al (2011) Causes of death and relative survival of older women after a breast cancer diagnosis. J Clin Oncol 29:1570\u20131577","journal-title":"J Clin Oncol"},{"key":"7327_CR5","doi-asserted-by":"publisher","first-page":"5272","DOI":"10.1002\/cncr.24617","volume":"115","author":"JJ Dignam","year":"2009","unstructured":"Dignam JJ, Huang L, Ries L et al (2009) Estimating breast cancer-specific and other-cause mortality in clinical trial and population-based cancer registry cohorts. Cancer 115:5272\u20135283","journal-title":"Cancer"},{"key":"7327_CR6","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dju156","author":"NB Boekel","year":"2014","unstructured":"Boekel NB, Schaapveld M, Gietema JA et al (2014) Cardiovascular morbidity and mortality after treatment for ductal carcinoma in situ of the breast. J Natl Cancer Inst. https:\/\/doi.org\/10.1093\/jnci\/dju156","journal-title":"J Natl Cancer Inst"},{"key":"7327_CR7","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1097\/SLA.0000000000002239","volume":"267","author":"LE Elshof","year":"2018","unstructured":"Elshof LE, Schmidt MK, Rutgers EJT et al (2018) Cause-specific mortality in a Population-based Cohort of 9799 women treated for Ductal Carcinoma in situ. Ann Surg 267:952\u2013958","journal-title":"Ann Surg"},{"key":"7327_CR8","doi-asserted-by":"publisher","first-page":"3777","DOI":"10.1245\/s10434-012-2413-4","volume":"19","author":"R Alvarado","year":"2012","unstructured":"Alvarado R, Lari SA, Roses RE et al (2012) Biology, treatment, and outcome in very young and older women with DCIS. Ann Surg Oncol 19:3777\u20133784","journal-title":"Ann Surg Oncol"},{"key":"7327_CR9","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1634\/theoncologist.2014-0184","volume":"19","author":"EO Jenkins","year":"2014","unstructured":"Jenkins EO, Deal AM, Anders CK et al (2014) Age-specific changes in intrinsic breast cancer subtypes: a focus on older women. Oncologist 19:1076\u20131083","journal-title":"Oncologist"},{"key":"7327_CR10","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1016\/S1047-2797(03)00043-7","volume":"13","author":"GL Anderson","year":"2003","unstructured":"Anderson GL, Manson J, Wallace R et al (2003) Implementation of the women\u2019s Health Initiative study design. Ann Epidemiol 13:S5\u201317","journal-title":"Ann Epidemiol"},{"key":"7327_CR11","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1001\/jama.295.6.629","volume":"295","author":"RL Prentice","year":"2006","unstructured":"Prentice RL, Caan B, Chlebowski RT et al (2006) Low-fat dietary pattern and risk of invasive breast cancer: the women\u2019s Health Initiative Randomized Controlled Dietary Modification Trial. JAMA 295:629\u2013642","journal-title":"JAMA"},{"key":"7327_CR12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.00435","author":"RT Chlebowski","year":"2020","unstructured":"Chlebowski RT, Aragaki AK, Anderson GL et al (2020) Dietary Modification and Breast Cancer Mortality: Long-Term Follow-Up of the Women\u2019s Health Initiative Randomized Trial. J Clin Oncol. https:\/\/doi.org\/10.1200\/JCO.19.00435","journal-title":"J Clin Oncol"},{"key":"7327_CR13","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1056\/NEJMoa0807684","volume":"360","author":"RT Chlebowski","year":"2009","unstructured":"Chlebowski RT, Kuller LH, Prentice RL et al (2009) Breast cancer after use of estrogen plus progestin in postmenopausal women. N Engl J Med 360:573\u2013587","journal-title":"N Engl J Med"},{"key":"7327_CR14","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1001\/jama.2020.9482","volume":"324","author":"RT Chlebowski","year":"2020","unstructured":"Chlebowski RT, Anderson GL, Aragaki AK et al (2020) Association of menopausal hormone therapy with breast cancer incidence and mortality during long-term follow-up of the women\u2019s health initiative randomized clinical trials. JAMA 324:369\u2013380","journal-title":"JAMA"},{"key":"7327_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v042.i08","volume":"42","author":"DE Ho","year":"2011","unstructured":"Ho DE, Imai K, King G et al (2011) MatchIt: nonparametric preprocessing for parametric causal inference. J Stat Softw 42:1\u201328","journal-title":"J Stat Softw"},{"key":"7327_CR16","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1093\/oxfordjournals.aje.a117191","volume":"140","author":"JW Rich-Edwards","year":"1994","unstructured":"Rich-Edwards JW, Corsano KA, Stampfer MJ (1994) Test of the national death index and equifax nationwide death search. Am J Epidemiol 140:1016\u20131019","journal-title":"Am J Epidemiol"},{"key":"7327_CR17","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1200\/JCO.19.02888","volume":"38","author":"ES Hwang","year":"2020","unstructured":"Hwang ES, Solin L (2020) De-escalation of locoregional therapy in low-risk disease for DCIS and early-stage invasive cancer. J Clin Oncol 38:2230\u20132239","journal-title":"J Clin Oncol"},{"key":"7327_CR18","doi-asserted-by":"publisher","first-page":"m1570","DOI":"10.1136\/bmj.m1570","volume":"369","author":"GS Mannu","year":"2020","unstructured":"Mannu GS, Wang Z, Broggio J et al (2020) Invasive breast cancer and breast cancer mortality after ductal carcinoma in situ in women attending for breast screening in England, 1988\u20132014: population based observational cohort study. BMJ 369:m1570","journal-title":"BMJ"},{"key":"7327_CR19","doi-asserted-by":"publisher","first-page":"e2017124","DOI":"10.1001\/jamanetworkopen.2020.17124","volume":"3","author":"V Giannakeas","year":"2020","unstructured":"Giannakeas V, Sopik V, Narod SA (2020) Association of a diagnosis of ductal carcinoma in situ with death from breast cancer. JAMA Netw Open 3:e2017124","journal-title":"JAMA Netw Open"},{"key":"7327_CR20","doi-asserted-by":"publisher","first-page":"4120","DOI":"10.1200\/JCO.20.01382","volume":"38","author":"MJ Piccart","year":"2020","unstructured":"Piccart MJ, Hilbers FS, Bliss JM et al (2020) Road map to safe and well-designed de-escalation trials of systemic adjuvant therapy for solid tumors. J Clin Oncol 38:4120\u20134129","journal-title":"J Clin Oncol"},{"key":"7327_CR21","doi-asserted-by":"publisher","first-page":"3152","DOI":"10.1200\/JCO.19.01472","volume":"37","author":"K Visvanathan","year":"2019","unstructured":"Visvanathan K, Fabian CJ, Bantug E et al (2019) Use of endocrine therapy for breast cancer risk reduction: ASCO clinical practice guideline update. J Clin Oncol 37:3152\u20133165","journal-title":"J Clin Oncol"},{"key":"7327_CR22","doi-asserted-by":"publisher","first-page":"381","DOI":"10.7326\/M18-1199","volume":"172","author":"X Garcia-Albeniz","year":"2020","unstructured":"Garcia-Albeniz X, Hernan MA, Logan RW et al (2020) Continuation of annual screening mammography and breast cancer mortality in women older Than 70 years. Ann Intern Med 172:381\u2013389","journal-title":"Ann Intern Med"},{"key":"7327_CR23","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.jss.2020.07.023","volume":"256","author":"G Squeo","year":"2020","unstructured":"Squeo G, Malpass JK, Meneveau M et al (2020) Long-term impact of CALGB 9343 on radiation utilization. J Surg Res 256:577\u2013583","journal-title":"J Surg Res"},{"key":"7327_CR24","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1200\/JCO.2012.45.2615","volume":"31","author":"KS Hughes","year":"2013","unstructured":"Hughes KS, Schnaper LA, Bellon JR et al (2013) Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. J Clin Oncol 31:2382\u20132387","journal-title":"J Clin Oncol"},{"key":"7327_CR25","doi-asserted-by":"publisher","first-page":"691","DOI":"10.6004\/jnccn.2022.0030","volume":"20","author":"WJ Gradishar","year":"2022","unstructured":"Gradishar WJ, Moran MS, Abraham J et al (2022) Breast cancer, version 3.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 20:691\u2013722","journal-title":"J Natl Compr Canc Netw"},{"key":"7327_CR26","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1001\/jamaoncol.2015.2510","volume":"1","author":"SA Narod","year":"2015","unstructured":"Narod SA, Iqbal J, Giannakeas V et al (2015) Breast cancer mortality after a diagnosis of ductal carcinoma in situ. JAMA Oncol 1:888\u2013896","journal-title":"JAMA Oncol"},{"key":"7327_CR27","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1016\/S0140-6736(99)05036-9","volume":"353","author":"B Fisher","year":"1999","unstructured":"Fisher B, Dignam J, Wolmark N et al (1999) Tamoxifen in treatment of intraductal breast cancer: national surgical adjuvant breast and bowel project B-24 randomised controlled trial. Lancet 353:1993\u20132000","journal-title":"Lancet"},{"key":"7327_CR28","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1093\/jncimonographs\/lgq039","volume":"2010","author":"C Correa","year":"2010","unstructured":"Early Breast Cancer Trialists Collaborative, Correa C, McGale P et al (2010) Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr 2010:162\u2013177","journal-title":"J Natl Cancer Inst Monogr"},{"key":"7327_CR29","doi-asserted-by":"publisher","first-page":"3574","DOI":"10.1200\/JCO.21.01083","volume":"39","author":"B McCormick","year":"2021","unstructured":"McCormick B, Winter KA, Woodward W et al (2021) Randomized phase III trial evaluating radiation following surgical excision for good-risk ductal carcinoma in situ: long-term report from nrg oncology\/RTOG 9804. J Clin Oncol 39:3574\u20133582","journal-title":"J Clin Oncol"},{"key":"7327_CR30","doi-asserted-by":"publisher","first-page":"100731","DOI":"10.1016\/j.adro.2021.100731","volume":"6","author":"CL Liveringhouse","year":"2021","unstructured":"Liveringhouse CL, Washington IR, Diaz R et al (2021) Genomically guided breast radiation therapy: a review of the current data and future directions. Adv Radiat Oncol 6:100731","journal-title":"Adv Radiat Oncol"},{"key":"7327_CR31","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1093\/jnci\/djr027","volume":"103","author":"IL Wapnir","year":"2011","unstructured":"Wapnir IL, Dignam JJ, Fisher B et al (2011) Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. J Natl Cancer Inst 103:478\u2013488","journal-title":"J Natl Cancer Inst"},{"key":"7327_CR32","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S1470-2045(10)70266-7","volume":"12","author":"J Cuzick","year":"2011","unstructured":"Cuzick J, Sestak I, Pinder SE et al (2011) Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK\/ANZ DCIS trial. Lancet Oncol 12:21\u201329","journal-title":"Lancet Oncol"},{"key":"7327_CR33","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/S0140-6736(15)01129-0","volume":"387","author":"JF Forbes","year":"2016","unstructured":"Forbes JF, Sestak I, Howell A et al (2016) Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial. Lancet 387:866\u2013873","journal-title":"Lancet"},{"key":"7327_CR34","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S0140-6736(15)01168-X","volume":"387","author":"RG Margolese","year":"2016","unstructured":"Margolese RG, Cecchini RS, Julian TB et al (2016) Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial. Lancet 387:849\u2013856","journal-title":"Lancet"},{"key":"7327_CR35","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1001\/jama.295.1.39","volume":"295","author":"BV Howard","year":"2006","unstructured":"Howard BV, Manson JE, Stefanick ML et al (2006) Low-fat dietary pattern and weight change over 7 years: the women\u2019s Health Initiative Dietary Modification Trial. JAMA 295:39\u201349","journal-title":"JAMA"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-024-07327-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-024-07327-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-024-07327-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T06:06:38Z","timestamp":1720418798000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-024-07327-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,11]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["7327"],"URL":"https:\/\/doi.org\/10.1007\/s10549-024-07327-5","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"type":"print","value":"0167-6806"},{"type":"electronic","value":"1573-7217"}],"subject":[],"published":{"date-parts":[[2024,5,11]]},"assertion":[{"value":"31 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr Chlebowski is a consultant for Novartis, AstraZeneca, Pfizer and UpToDate. No other author reported conflicts.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}